hotspot -WSS

hotspot

author：Wikipedia 2025-09-29 07:35:18 - browse：3

Mifepristone (Mifeprex) and Misoprostol — A federal appeals court on Wednesday ruled to restrict access to the abortion pill mifepristone but not remove it from the market entirely. ROBYN BECK/AFP via Getty Images

A federal appeals court on Wednesday ruled to restrict access to the abortion pill mifepristone but not remove it from the market entirely, partially upholding a lower court’s decision.

The decision from the three-judge panel of the 5th U.S. Circuit Court of Appeals would effectively block mail-order prescriptions of the pill. However, access will remain unchanged for now, as the Supreme Court issued an emergency order this spring to preserve the status quo while the case goes through the appeals process.

The case is all but assured to head to the highest court, which last year overturned Roe v. Wade. Since the ruling, 14 states have implemented abortion bans and another 11 have imposed limits, some up to six weeks of pregnancy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

knowledge

hotspot

WSS

H5N1 virus can be tracked in retail milk, scientists say

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Bird flu surveillance in wastewater gets boost from consortium

Senate HELP committee spars over health care workforce policies

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Bird flu surveillance in wastewater gets boost from consortium

hotspot

hotspot

Wikipedia

In Memoriam: Notable people who died in 2023

Biogen joins immunology wave with $1.15 billion acquisition of HI

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Drug for rare kidney disease narrowly misses mark in clinical trial

Hollywood unions extend contract negotiations for actors

Listen: A conversation with researcher Kevin Esvelt on biosecurity

The cancer drug shortage isn’t new — and neither are the solutions

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

The high cost of giving birth even with insurance

Eyeing GLP

focus

Hearing on Medicare drug price negotiation gets unusually heated

Second xenotransplant done with gene

Senate HELP committee spars over health care workforce policies

Bird flu surveillance in wastewater gets boost from consortium

Cue Health, Covid

Senate HELP committee spars over health care workforce policies

focus

knowledge

hotspot

focus